 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present at Cowens 42nd Annual Healthcare Conference being held virtually March 7-9, 2022. Cowens 42nd Annual Healthcare Conference Date: Tuesday, March 8, 2022 Time: 2:50 PM ET The presentation will be webcast live and available for replay under News Events in the Investo 